Expand access to anti-obesity medications today

Obesity is a serious disease that affects millions of hardworking Americans, and it is not just a matter of lifestyle choice. Modern obesity medications, when combined with diet and exercise, provide proven health benefits by reducing the risks of heart disease, diabetes, stroke, and certain cancers.

 

Without access to these life-changing treatments, many individuals—particularly those in working-class and minority communities—face higher risks of debilitating health conditions, leading to costly hospital stays and long-term care. Covering these medications under Medicare and Medicaid will save lives and reduce the financial strain on our healthcare system.

 

The outdated rules prohibiting coverage for weight-loss medications fail to reflect our modern understanding of obesity as a disease. The proposed rule is a step in the right direction, recognizing that obesity treatment is essential for improving health and reducing chronic illnesses.

 

A recent Joint Economic Committee report shows obesity could cost our nation nearly $9 trillion in excess medical expenses over the next decade. Expanding access to anti-obesity medications is not only the right thing to do but also a smart investment in healthier communities, a healthier workforce, and a more sustainable healthcare system.

 

Sincerely,